In Study TRA100773B and Study TRA100773A (referred to as Study 773B and Study 773A, respectively [NCT00102739]), patients who had completed at least one prior ITP therapy and who had a platelet count less than 30 x 109/L were randomized to receive either eltrombopag or placebo daily for up to 6 weeks, followed by 6 weeks off therapy
heart, liver, and kidney issues
Skin injections, particularly those containing active ingredients like glutathione, often need rigorous clinical testing and evidence of safety
The public is advised to always check if a food product or food supplement is registered with the FDA by using the FDA Verification Portal feature accessible at
Once the study concluded, pQCT scans were performed on the femurs to gather additional data
[DOI] [Google Scholar] 224.Reichard J.F., Sartor M.A., Puga A